We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Radiation Oncology Research

Improving the Lives of Cancer Patients through Research & Discovery

At University Hospitals Seidman Cancer Center, our sole purpose is to improve the lives of cancer patients.

Transformational innovative research is intrinsic to our philosophy of providing the best care for our patients.

It all begins with an idea. Here at UH Seidman Cancer Center and Case Western Reserve University Department of Radiation Oncology, we don't simply want to read the guidelines...we want to create content that helps the lives of cancer patients that changes the guidelines. From bench to bedside to community outreach, we believe good is never good enough; cancer will rest for no one, and neither will we.

Corey Speers, MD, PhD

Corey Speers, MD, PhD

Vice Chair of Research, Radiation Oncology
Director of the Phase I Clinical Trials Program
Associate Professor at Case Western Reserve University

Case Comprehensive Cancer Center

University Hospitals Seidman Cancer Center is one of the best cancer hospitals in the country for over 20 consecutive years by U.S. News & World Report.

UH Seidman Cancer Center is part of the National Cancer Institute (NCI)-designated Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine – one of an elite group of 53 such comprehensive cancer hospitals in the U.S. The Case Comprehensive Cancer Center has an “Exceptional” rating from the NCI, a rating only seven NCI-designated comprehensive cancer centers currently hold.

Pioneering Cutting-Edge Technology and Clinical Trials

UH Seidman Cancer Center’s Department of Radiation Oncology has also pioneered numerous cutting-edge technologies and treatments through our dedication to the design and conduct of clinical trials.

Our Research Includes:

Our center was the 1st center in the world to be recognized as a SpaceOAR Center of Excellence for creating a multi-disciplinary program for patients with prostate cancer to reduce their side effects and improve their quality of life.
Led international efforts in personalizing prostate cancer care through genomic and artificial intelligence biomarkers and novel treatment combinations.
Developed the International Spine Oncology Consortium Guidelines for managing spine metastasis.
Created and validated multiple 1st in class biomarkers for women with breast cancer to personalize which women benefit from radiotherapy.
Actively assessing a promising novel clinical trial combining a DNA repair inhibitor with radiation therapy for lung cancer.
Work closely with our nationally recognized Phase I program to ensure the latest treatment options are available to our patients.